Press release
Clinvigilant Research is Now a CDSCO-approved CRO
Ahmedabad, India - [Jul 9, 2025] - Clinvigilant Research, a leading Clinical Research Organization (CRO), is proud to announce its official registration and approval by the Central Drugs Standard Control Organization (CDSCO), in full compliance with the G.S.R 581(E) regulation.
This milestone underscores Clinvigilant's steadfast commitment to regulatory excellence, ethical conduct, and the highest standards of quality in clinical research across India.
In alignment with the recent regulatory updates introduced through G.S.R 581(E), all CROs operating in India are now required to obtain formal registration with CDSCO. Clinvigilant's timely approval highlights the organization's proactive approach to compliance, quality management, and operational readiness.
"This approval is more than a regulatory checkbox - it's a reflection of our core values: integrity, accountability, and scientific rigor," said Bhumi Vyas, Director of Quality Assurance at Clinvigilant Research. "Our team has worked diligently to meet and exceed CDSCO requirements, ensuring that our partners can move forward with confidence and trust."
What This Means for Our Stakeholders:
Sponsors can rely on Clinvigilant for fully compliant, high-quality clinical operations backed by regulatory transparency.
Sites benefit from streamlined collaboration with a CRO dedicated to ethical standards, operational precision, and data integrity.
CRO Partners and industry peers can trust in a partner who prioritizes clear governance, regulatory alignment, and long-term credibility.
Clinvigilant's CDSCO approval enables the organization to further expand its services across India while reinforcing its role as a trusted partner in clinical development.
Block C, 10th Floor,
Titanium Business Park,
Near Makarba Railway Crossing,
Ahmedabad 380051, Gujarat, India
-
Clinvigilant Research is a full-service CRO dedicated to delivering high-quality, compliant, and ethically driven clinical trial solutions. With expertise across early-phase to post-marketing studies, we provide end-to-end clinical trial services to sponsors, sites, CROs & others. For More Information Visit https://www.clinvigilant.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Clinvigilant Research is Now a CDSCO-approved CRO here
News-ID: 4110819 • Views: …
More Releases for CRO
Biomedical CRO Market Emerging Trends for 2032
The Biomedical Contract Research Organization (CRO) market is experiencing a transformative phase marked by innovation, growth, and strategic collaborations. As the global focus on healthcare intensifies, the relevance of Biomedical CROs is increasingly pronounced, with their scope encompassing a diverse range of applications across critical sectors. These organizations are pivotal in supporting the development of biopharmaceuticals and medical devices, thus playing an essential role in advancing healthcare solutions that benefit…
Dermatology CRO Market Global outlook 2024 to 2031
In recent years, the global Dermatology CRO Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Dermatology CRO Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including Porters Five…
Global Veterinary CRO & CDMO Market Size & Trends
According to a new market research report published by Global Market Estimates, the global veterinary CRO & CDMO market is expected to grow at a CAGR of 9.1% from 2023 to 2028.
The growing awareness regarding the importance of animal health and welfare has led to increased investments in veterinary pharmaceutical research and development. This awareness is driven by the rising concern for the well-being of pets, livestock, and animals used…
Global Contract Research Organization (CRO) Services Market
According to a new market research report published by Global Market Estimates, the Global Contract Research Organization (CRO) Services Market is expected to grow at a CAGR of 10.2% from 2023 to 2028.
The growth of the contract research organization (CRO) Services Market is fuelled by factors including the rising preference for outsourcing clinical trials, increasing investments in research and development by pharmaceutical and biopharmaceutical companies, the growing complexities in drug…
Contract Research Organization (CRO) Services Market - Efficiency, Expertise, Ex …
Newark, New Castle, USA: The "Contract Research Organization (CRO) Services Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Contract Research Organization (CRO) Services Market: https://www.growthplusreports.com/report/contract-research-organization-cro-services-market/7630
This latest report…
Biopharmaceutical CMO and CRO Market
The Biopharmaceutical CMO and CRO Market crossed US$ 32.25 billion in 2022 and is expected to hit US$ 54.13 billion by 2030, recording a CAGR of 6.5% during the forecast period
Pharmaceutical and biotech companies focus on R&D activities to innovate new molecules and therapeutic platforms to deal with chronic diseases and rare ailments; they also extensively invest in R&D activities to develop various therapeutic applications with strong medical and commercial…
